Impact of Curcumin and Pentoxiphylline on Chronic Kidney Disease Patients

Summary

The aim of the study is to evaluate the impact of turmeric and pentoxiphylline on serum levels of protein-bound uremic toxin (p-cresyl sulfate), oxidative stress biomarker level (Malonaldehyde), inflammatory biomarker level (Highly sensitive C-reactive protein). In addition to the evaluation of its effect on metabolic profile and disease progression in chronic kidney disease patients.

Timeline

Start

2023-10-01

Primary completion

2024-09-01

Completion

2024-10-01

Drugs

Indications